February 1: Speakers LINK
1-2 February 2022
Minister for Health and Social Affairs
Digital participation
Professor, National Cancer Coordinator, chair of the Confederation of Regional Cancer Centres, co-founder and chair of Vision Zero Cancer, Sweden
Chief Medical Officer and Oncology Chief Development Officer, AstraZeneca
Digital participation
Professor of Leadership and Innovation, Stockholm School of Economics, Advisory Board of the European Innovation Council at the European Commission
Digital participation
Professor of Surgery at Karolinska Institutet, Senior Consultant Colorectal Surgeon at Karolinska University Hospital
MD, PhD, Personalised Medicine and Patient-centric Innovation at Vision Zero Cancer, Founder Melanoma Patient Network Europe
Chief Scientific Officer, Cellink
Chief Medical Officer, Kaiku Health – a part of Elekta
Professor in Oncology, Umeå University, Director of Research Development and Innovation, Region Västerbotten, Sweden
Digital participation
Professor of Radiology at Lund University and Senior Consultant Radiologist at Skåne University Hospital
Digital participation
Professor in Cancer Epidemiology, Karolinska Institutet, Sweden
Digital participation
Clinical Associate Professor, Honorary Consultant, at Queen Mary Hospital, Hong Kong, and HKU-Shenzhen Hospital
Digital participation
Founder and Director of the Medical Oncology Service at Burjeel Medical City - VPS healthcare
MD, Executive Director, Research and Innovation Centre at the Department of Health
Executive Director of Community Health Sector, Abu Dhabi Public Health Center
CEO, Karolinska University Hospital
Vice President, Sales & Marketing, EMEA Olink Proteomics AB
Professor Clinical Genetics, Karolinska Institutet; Senior Consultant, Karolinska University Hospital; Chair, Genomic Medicine Sweden
Associate Professor of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins Medicine
Digital participation
Director MR Linac Region Turkey, India, Middle East and Africa at Elekta
Policy Expert, the Swedish Association of the Pharmaceutical Industry
Chief Digital Health Officer R&D, AstraZeneca
Digital participation